What is EnsoData?
EnsoData is a Madison, Wisconsin-based software company dedicated to designing advanced healthcare software. Its core technology focuses on tracking and analyzing critical health data, such as heart rhythm and glycemic index, to empower informed health decisions. By providing sophisticated analytical tools, EnsoData aims to enhance patient care and streamline health management through data-driven insights. The company's work positions it as a key player in the evolving landscape of digital health and personalized medicine.
How much funding has EnsoData raised?
EnsoData has raised a total of $50.7M across 5 funding rounds:
Angel/Seed
$550K
Private Equity
$987K
Debt
$150K
Series A
$29M
Series B
$20M
Angel/Seed (2016): $550K with participation from HealthX Ventures
Private Equity (2017): $987K, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Series A (2022): $29M featuring Inspire Medical Systems, Zetta Venture Partners, and Venture Investors
Series B (2025): $20M backed by Zetta Venture Partners, Questa Capital, Supermoon Capital, and Inspire Medical Systems
Key Investors in EnsoData
Zetta Venture Partners
Zetta Venture Partners is a venture capital firm that focuses on providing zero to one capital and hands-on support to AI native startups. They aim to partner with impactful companies in the AI and infrastructure sectors, specifically targeting builders of AI applications, infrastructure, and developer tools. Their mission is to be the most important partner for these innovative founders. The firm operates from locations in San Francisco and New York City.
Questa Capital
Questa Capital invests in innovative healthcare companies that aim to enhance patient experiences, reduce costs, and improve overall population health. They partner with exceptional teams to support the development of next-generation healthcare solutions, such as connected AEDs, telemedicine for opioid recovery, and advanced neurological therapies for children. Their portfolio includes companies like Avive, Bicycle Health, Calyxo, ClaritasRx, Cortica, and DispatchHealth, each focused on transforming healthcare delivery. Questa Capital is dedicated to advancing healthcare and enhancing lives through strategic investments.
Venture Investors
Venture Investors Health Fund is dedicated to shaping the future of healthcare by investing in groundbreaking innovations. With $350 million in assets under management and a strong connection to world-class research universities, they focus on transformative health solutions that improve lives. Their portfolio includes companies like EarliTec and EnsoData, which are pioneering advancements in autism diagnosis and sleep diagnostics, respectively. The firm is committed to supporting university spinouts and enhancing the healthcare innovation ecosystem.
What's next for EnsoData?
With the recent influx of $20M in a major strategic investment and a cumulative total of $50.7M, EnsoData is poised for significant scaling and innovation. This substantial backing, particularly from investors like Zetta Venture Partners, Questa Capital, and Venture Investors Health Fund, suggests a strong confidence in EnsoData's technology and market strategy. The company is likely to leverage this capital to expand its product offerings, enhance its data analytics capabilities, and broaden its market reach within the healthcare industry. Future developments may include deeper integration with electronic health records, advanced predictive analytics for disease management, and strategic partnerships to accelerate adoption.
See full EnsoData company page
